These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25376496)

  • 1. A click-and-release approach to CO prodrugs.
    Wang D; Viennois E; Ji K; Damera K; Draganov A; Zheng Y; Dai C; Merlin D; Wang B
    Chem Commun (Camb); 2014 Dec; 50(100):15890-3. PubMed ID: 25376496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An esterase-activated click and release approach to metal-free CO-prodrugs.
    Ji X; Ji K; Chittavong V; Yu B; Pan Z; Wang B
    Chem Commun (Camb); 2017 Jul; 53(59):8296-8299. PubMed ID: 28685779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-Sensitive metal-free carbon monoxide prodrugs with tunable and predictable release rates.
    Ji X; De La Cruz LKC; Pan Z; Chittavong V; Wang B
    Chem Commun (Camb); 2017 Aug; 53(69):9628-9631. PubMed ID: 28809970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Click and Release: A Chemical Strategy toward Developing Gasotransmitter Prodrugs by Using an Intramolecular Diels-Alder Reaction.
    Ji X; Zhou C; Ji K; Aghoghovbia RE; Pan Z; Chittavong V; Ke B; Wang B
    Angew Chem Int Ed Engl; 2016 Dec; 55(51):15846-15851. PubMed ID: 27879021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies toward Organic Carbon Monoxide Prodrugs.
    Ji X; Wang B
    Acc Chem Res; 2018 Jun; 51(6):1377-1385. PubMed ID: 29762011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organic CO Prodrugs: Structure-CO-Release Rate Relationship Studies.
    Pan Z; Chittavong V; Li W; Zhang J; Ji K; Zhu M; Ji X; Wang B
    Chemistry; 2017 Jul; 23(41):9838-9845. PubMed ID: 28544290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward carbon monoxide based therapeutics: carbon monoxide in a pill.
    Ji X; Wang B
    Pharm Pat Anal; 2017 Jul; 6(4):171-177. PubMed ID: 28696157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esterase-Sensitive and pH-Controlled Carbon Monoxide Prodrugs for Treating Systemic Inflammation.
    Ji X; Pan Z; Li C; Kang T; De La Cruz LKC; Yang L; Yuan Z; Ke B; Wang B
    J Med Chem; 2019 Mar; 62(6):3163-3168. PubMed ID: 30816714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Click and Release: A High-Content Bioorthogonal Prodrug with Multiple Outputs.
    Ji X; Aghoghovbia RE; De La Cruz LKC; Pan Z; Yang X; Yu B; Wang B
    Org Lett; 2019 May; 21(10):3649-3652. PubMed ID: 31063383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Click and Release: SO
    Ji X; El-Labbad EM; Ji K; Lasheen DS; Serya RA; Abouzid KA; Wang B
    Org Lett; 2017 Feb; 19(4):818-821. PubMed ID: 28133965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated charcoal dispersion of carbon monoxide prodrugs for oral delivery of CO in a pill.
    Yang X; Lu W; Wang M; De La Cruz LK; Tan C; Wang B
    Int J Pharm; 2022 Apr; 618():121650. PubMed ID: 35276229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visible-Light-Activated Quinolone Carbon-Monoxide-Releasing Molecule: Prodrug and Albumin-Assisted Delivery Enables Anticancer and Potent Anti-Inflammatory Effects.
    Popova M; Lazarus LS; Ayad S; Benninghoff AD; Berreau LM
    J Am Chem Soc; 2018 Aug; 140(30):9721-9729. PubMed ID: 29983046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CO as a therapeutic agent: discovery and delivery forms.
    Yang XX; Ke BW; Lu W; Wang BH
    Chin J Nat Med; 2020 Apr; 18(4):284-295. PubMed ID: 32402406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrichment-triggered prodrug activation demonstrated through mitochondria-targeted delivery of doxorubicin and carbon monoxide.
    Zheng Y; Ji X; Yu B; Ji K; Gallo D; Csizmadia E; Zhu M; Choudhury MR; De La Cruz LKC; Chittavong V; Pan Z; Yuan Z; Otterbein LE; Wang B
    Nat Chem; 2018 Jul; 10(7):787-794. PubMed ID: 29760413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward Carbon Monoxide-Based Therapeutics: Critical Drug Delivery and Developability Issues.
    Ji X; Damera K; Zheng Y; Yu B; Otterbein LE; Wang B
    J Pharm Sci; 2016 Feb; 105(2):406-416. PubMed ID: 26869408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Click, Release, and Fluoresce: A Chemical Strategy for a Cascade Prodrug System for Codelivery of Carbon Monoxide, a Drug Payload, and a Fluorescent Reporter.
    De La Cruz LKC; Benoit SL; Pan Z; Yu B; Maier RJ; Ji X; Wang B
    Org Lett; 2018 Feb; 20(4):897-900. PubMed ID: 29380605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visible light-controlled carbon monoxide delivery combined with the inhibitory activity of histone deacetylases from a manganese complex for an enhanced antitumor therapy.
    Zhang HL; Yu YT; Wang Y; Tang Q; Yang SP; Liu JG
    J Inorg Biochem; 2021 Mar; 216():111354. PubMed ID: 33454609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemiexcitation-Triggered Prodrug Activation for Targeted Carbon Monoxide Delivery.
    Min Q; Ni Z; You M; Liu M; Zhou Z; Ke H; Ji X
    Angew Chem Int Ed Engl; 2022 Jun; 61(26):e202200974. PubMed ID: 35385195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing drug molecules for therapy with carbon monoxide.
    Romão CC; Blättler WA; Seixas JD; Bernardes GJ
    Chem Soc Rev; 2012 May; 41(9):3571-83. PubMed ID: 22349541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward "CO in a Pill": Silica-Immobilized Organic CO Prodrugs for Studying the Feasibility of Systemic Delivery of CO via
    Yang X; Tripathi R; Wang M; Lu W; Anifowose A; Tan C; Wang B
    Mol Pharm; 2023 Mar; 20(3):1850-1856. PubMed ID: 36802675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.